Cita APA

N., Z., M.I., A. B., E., B., I., C., J., E., N., O., . . . L., V. (2022). A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.

Citación estilo Chicago

N., Zozaya, et al. A Multi-criteria Decision Analysis On the Value of Nintedanib for Interstitial Lung Diseases. 2022.

Cita MLA

N., Zozaya, et al. A Multi-criteria Decision Analysis On the Value of Nintedanib for Interstitial Lung Diseases. 2022.